Increasing fracture incidence over 13 years in patients with rheumatoid arthritis from the IORRA cohort
Journal of Bone and Mineral Metabolism · 2025
DOI: 10.1007/s00774-025-01598-8 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Bone and Mineral Metabolism, 2025. Verfasst von Takefumi Furuya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Tokyo Women's Medical University School of Medicine, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo, 162-8666, Japan. furuyat2000@gma…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Fractures, Bone. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: This study aimed to evaluate fracture incidence in patients with rheumatoid arthritis (RA) over 13 years in the Institute of Rheumatology Rheumatoid Arthritis (IORRA) cohort study. MATERIALS AND METHODS: The IORRA is a prospective observational cohort study of Japanese patients with RA. Between 2011 and 2023, 10,257 patients with RA were enrolled. Clinical parameters and data on fractures were collected biannually using self-reported questionnaires. The fracture incidence, standardized by sex, age, and Japanese Health Assessment Questionnaire score, was calculated for each two-year period. RESULTS: From 2011 to 2023, the proportions of patients achieving Disease Activity Score in 28 joints remission, using biologic disease-modifying antirheumatic drugs, and taking osteoporosis medications increased (38.0% to 64.7%, 14.2% to 42.2%, and 31.6% to 38.3%, respectively), while the proportion of glucocorticoid use decreased (38.3% to 22.2%). The incidence of all and non-vertebral fractures increased from 47.2 and 36.7/1000 person-years in 2011 to 52.8 and 43.0/1000 person-years in 2023, respectively. Using 2023 as the reference, the standardized incidence ratios for all and non-vertebral fractures were: 2011-2012, 0.90 [95% confidence interval (CI) 0.82-0.98] and 0.86 (95% CI 0.78-0.95); 2013-2014, 0.88 (95% CI 0.81-0.96) and 0.84 (95% CI 0.76-0.93); 2015-2016, 0.94 (95% CI 0.86-1.02) and 0.89 (95% CI 0.80-0.98); 2017-2018, 0.97 (95% CI 0.88-1.07) and 0.94 (95% CI 0.84-1.05); 2019-2020, 0.95 (95% CI 0.84-1.07) and 0.93 (95% CI 0.81-1.06); 2021-2022, 1.00 (95% CI 0.89-1.13) and 0.99 (95% CI 0.86-1.13). CONCLUSION: Despite advancements in RA management over 13 years, fracture incidence may have increased in patients with RA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Tokyo Women's Medical University School of Medicine, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo, 162-8666, Japan. furuyat2000@gmail.com.
- Wakabayashi Clinic, Tokyo, Japan. furuyat2000@gmail.com.
- Department of Rheumatology, Tokyo Women's Medical University School of Medicine, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo, 162-8666, Japan.
- Research Administration Center, Showa University, Tokyo, Japan.
- Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
- Sanno Medical Center, Tokyo, Japan.
Zitieren
APA
Furuya, T., Inoue, E., Yamanaka, H., Harigai, M., & Tanaka, E. (2025). Increasing fracture incidence over 13 years in patients with rheumatoid arthritis from the IORRA cohort. Journal of Bone and Mineral Metabolism. https://doi.org/10.1007/s00774-025-01598-8
Vancouver
Furuya T, Inoue E, Yamanaka H, Harigai M, Tanaka E. Increasing fracture incidence over 13 years in patients with rheumatoid arthritis from the IORRA cohort. Journal of Bone and Mineral Metabolism. 2025. doi:10.1007/s00774-025-01598-8
BibTeX
@article{Furuya2025,
author = {Furuya, Takefumi and Inoue, Eisuke and Yamanaka, Hisashi and Harigai, Masayoshi and Tanaka, Eiichi},
title = {Increasing fracture incidence over 13 years in patients with rheumatoid arthritis from the IORRA cohort},
journal = {Journal of Bone and Mineral Metabolism},
year = {2025},
doi = {10.1007/s00774-025-01598-8}
}
EUVIMED